T02358 (1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-10,21-二甲氧基-6,8,12,14,20,26-六甲基-1,5,1,28,29-五氧代-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-二十四氢-3H-23,27-环氧吡啶并[2,1-c][1]氧杂[4]氮杂环三十一碳烷-3-基)丙基)-

(1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

别名：西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物展开

CAS No. : 162635-04-3

分子式： C₅₆H₈₇NO₁₆

分子量： 1030.2871

大包装询价? 收藏产品

自营

货号	规格	目录价	您的价格	货期	数量	购物车
T02358-100mg	100mg	¥1418.00
T02358-250mg	250mg	¥2678.00

中文名称	(1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-10,21-二甲氧基-6,8,12,14,20,26-六甲基-1,5,1,28,29-五氧代-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-二十四氢-3H-23,27-环氧吡啶并[2,1-c][1]氧杂[4]氮杂环三十一碳烷-3-基)丙基)-
中文别名	西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物
英文名称	(1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
英文别名	Temsirolimus;Temsirolimus (CCI-779, NSC 683864);42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]Rapamycin;Temsirolimus (cell cycle inhibitor 779,CCI-779,Torisel®);[14C]-Temsirolimus;CCI779;CCL-779;Rapamycin (42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid;TeMsiroliMus (~);TeMsiroliMus (CCI-779,Torisel);TeMsiroliMus (Torisel);CCI-779;Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate];C15182;NSC 683864;Temsirolimus(CCI-779);Torisel;624KN6GM2T;42-[3-Hydroxy-2-methylpropanoate;Cci 779;Temserolimus;Temsirolimus - Torisel;Rapamycin 42-(2,2-bis(hydroxymethyl)propionate);DSSTox_CID_20945;DSSTox_RID_79605;DSSTox_GSID_40945;42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin;Rapamycin 42-[3-hydroxy-2-(hydroxym;Rapamycin 42-ester with 2,2-bis-(hydroxymethyl)propionic acid;GTPL5892;Temsirolimus (>80%);Rapamycin 42-;CHEBI:79699;L01XE09;CHEMBL1201182;TEMSIROLIMUS [WHO-DD];BRD-K08177763-001-02-6;DTXCID0020945;TEMSIROLIMUS [INN];TEMSIROLIMUS [ORANGE BOOK];NCGC00167518-09;WAY-CCI 779;AKOS025142069;SR-01000898799-3;s1044;Q7699074;NSC-683864;CCG-264790;TEMSIROLIMUS [JAN];T3574;J-009958;MFCD00934421;Temsirolimus [USAN:INN:BAN:JAN];TEMSIROLIMUS [EMA EPAR];TEMSIROLIMUS (MART.);CBPNZQVSJQDFBE-FUXHJELOSA-N;Tox21_112515;AM84554;SCHEMBL18792;NCGC00167518-01;AB01274736-01;162635-04-3;TEMSIROLIMUS [MI];NCGC00167518-02;SR-01000898799;Temsirolimus [USAN];TEMSIROLIMUS [MART.];UNII-624KN6GM2T;Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate);Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];Temsirolimus, >=98% (HPLC);BDBM50343413;CAS-162635-04-3;HY-50910;(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate;A4I;DTXSID2040945;TEMSIROLIMUS [VANDF];CS-0129;NCGC00167518-05;42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin;HSDB 7931;AB01274736_02;temsirolimusum
CAS No.	162635-04-3
分子式	C₅₆H₈₇NO₁₆
分子量	1030.29
密度	1.21
沸点	1048.4±75.0 °C at 760 mmHg
蒸汽压	0.0±0.6 mmHg at 25°C
纯度	99.00%